A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.
We deliver transformative solutions that power real results. See how we can help.
Optimizing Supply Chain
Maximizing Value-Based Care
Transforming healthcare is more than our objective, it’s in our DNA. We’re dedicated to ensuring better health is just the beginning.
At every level of leadership, Premier’s experts are driving healthcare forward.
Board of Directors
Premier is more than a GPO. Combining robust analytics with consulting and advocacy, we’re changing the healthcare landscape for the better.
Find Out How
Collective purchasing power lowers costs across your organization.
Intelligence plus unparalleled analytics equals data-driven solutions.
It’s only impossible until it’s not. Premier and our team of experts are transforming care delivery.
Work with Premier members to lower costs, improve quality and safety and succeed in value-based care.
A voice for better healthcare policy is a voice for you.
Working closely with our members, we’re developing products and services to solve your most complex challenges.
Lower costs, greater efficiencies and a healthier bottom line.
Proven practices that result in better outcomes.
Intersecting specialty drugs with better management and data-driven best practices.
Controlling your future with integrated care delivery practices.
More savings and ROI is a win-win.
Data diving to deliver insights you can act on.
Data, inquiry and intervention services.
Our most recent insights, articles and more, all in one place.
View Our Latest
Discover what leading healthcare providers are achieving through Premier membership.
Stay informed with our white papers, webinars and e-books.
Browse our blog for a taste of what’s new and what’s next in healthcare.
Premier’s perspectives have been solicited by nationally renowned publications. Read on.
Read Premier’s latest announcements.
Catch our policy statements and perspectives on the latest in DC.
Find what you’re looking for, fast! Select a category or topic to get to what matters to you most.
This new partnership secures supply of amiodarone and sterile water, helping to stabilize the long-term supply of two medications vital for COVID-19 patient care.
Premier's purchasing data shows demand for drugs used to treat cardiovascular conditions and blood clots has soared.
CQ Roll Coll |
Data from Premier shared with CQ Roll Call shows that the use of propofol as a first-line sedative increased over 300 percent from 2019 to 2020.
Despite the increased demand, Premier members have been able to reliably access them through ProvideGx.
Premier urged HHS and Congress to provide additional relief hospitals and other providers need as they continue to respond to COVID-19.
The Washington Post |
Premier is urging the FDA to use its new powers quickly to investigate and anticipate drug shortages said the company’s senior director of advocacy, Soumi...
Fifteen drugs needed to treat Covid-19 patients were in or close to shortages by the end of March, according to Premier Survey.
Premier called on the FDA to take steps to strengthen payor adoption of biosimilars.
NBC Boston |
Premier's Soumi Saha provides discusses potential drug shortages due to an increased demand amidst COVID-19.
The New York Times |
Hospitals in particular are feeling the pinch in supplies. Premier found that drug shortages were pervasive in acute care settings.
Business Insider |
Premier survey finds drugs needed for COVID-19 patient care are quickly slipping into shortage.
Our recent survey found that 15 drugs essential to providing care for COVID-19 patients are currently in or very near shortage.
The bill provides a critical infusion of funding for the healthcare system to respond to the COVID-19 pandemic.
Nexstar Media Wire |
Premier's Soumi Saha says mass producing more of these drugs won’t be easy, especially when the active pharmaceutical ingredients come from overseas.
Our recommendations for CMS to address challenges that long-term care pharmacy and infusion pharmacy providers are facing during COVID-19.
The Washington Post |
Premier's Soumi Saha explains the spike in demand for two antimalarial drugs now on backorder.
The Financial Times |
Premier's Soumi Saha says hospitals need treatment guidelines or protocols from the CDC, or they will rush to buy every time small studies are released.
The Wall Street Journal |
Premier weighs in on the pharmaceutical supply of two drugs that could become a frontline treatment for COVID-19.
The Washington Post |
Premier data shows a 300% increase in orders of chloroquine and a 70% boost in orders of hydroxychloroquine.
Modern Healthcare |
Orders of chloroquine spiked 3,000% in March, according to data from Premier.
Health authorities should provide clearer guidance about drugs’ usage for COVID-19, per Premier.